Why Your Weight Loss Is Slowing Down on Mounjaro

The moment the scales stop moving

Picture the scene: Monday morning, pen in the fridge door as usual, dose taken, and then nothing on the scales for two weeks running. It can feel like the medicine has given up. It hasn't. What you're experiencing is a plateau, and every large tirzepatide trial (including SURMOUNT-1, which followed adults over 72 weeks) recorded them. Weight rarely falls in a straight line; it drops in bursts, levels off, sometimes nudges up slightly, then moves again.

The mechanism is partly metabolic. As your body reaches a lower weight, it adjusts its energy expenditure to match. Resting metabolism slows, hunger hormones partially recover, and your system begins defending the new set-point. This is not a Mounjaro failure — it is human physiology doing exactly what evolution designed it to do. Understanding that distinction matters, because the right response is very different from stopping or swapping treatment.

One other thing worth knowing: early rapid loss is often partly water and glycogen. Once that initial phase passes, the rate settles into something slower but more representative of true fat loss. Slower is not the same as stopped.

Why Mounjaro weight loss slowing down may reflect dose, not the medicine itself

Tirzepatide works along a titration schedule. Treatment begins at 2.5 mg, a dose whose job is to help your system adjust, not to produce peak weight loss. The full therapeutic effect builds as your prescriber moves you up through the 5, 7.5, 10, 12.5 and 15 mg strengths, typically in four-week steps. If you want a fuller picture of why weight loss can slow down on Mounjaro as the weeks progress, our clinical team has put together a detailed guide covering dose, physiology and what to expect at each stage. That is a clinical conversation, not a solo decision.

It is also worth considering what has changed in your routine. Appetite suppression from tirzepatide can gradually feel more familiar, and some people unconsciously eat more as the initial novelty of reduced hunger fades. Protein adequacy deserves particular attention at this stage: eating enough protein while in a calorie deficit helps preserve muscle mass, and muscle supports the metabolic rate that keeps weight moving. The factors shaping weight loss on Mounjaro are layered, and food quality matters alongside dose.

Sleep, stress and alcohol all interact with weight regulation too. Cortisol from poor sleep and chronic stress raises insulin resistance, which works against what tirzepatide is trying to achieve. These are not small considerations. They are, in fact, some of the most tractable levers available to you.

When slow weight loss on Mounjaro signals something worth reviewing

There is a meaningful difference between a plateau that lasts two to three weeks and one that has persisted for six weeks or more at an adequate dose. The latter warrants a proper clinical look. Thyroid function, for example, can affect metabolic rate and is occasionally the missing variable when someone does everything right but the scales refuse to shift. Insulin resistance, polycystic ovary syndrome and certain medications (including some antidepressants and corticosteroids) can all blunt the rate of loss.

For background on why weight loss can be slow on Mounjaro even when the medicine is working, our clinical team has written a detailed resource. And if cost has ever led you to consider a cheaper alternative, the context around Mounjaro pricing in the UK is worth reading, not least because the supply chain matters as much as the price for a prescription medicine.

The SURMOUNT-1 trial, published in the New England Journal of Medicine, showed average body-weight reductions of around 20–21% at the 15 mg dose over 72 weeks. Most participants did not achieve that in a straight line. Plateaus were part of the journey for the majority. If your progress has stalled, the evidence suggests continuing with supervised treatment, reviewing dose and lifestyle factors, and being patient, not abandoning a treatment that, over a full course, produces substantial results.

What you can actually change right now

A few practical levers are within your control today. First, track your food honestly for a week, not to punish yourself, but to see whether caloric intake has crept up without your noticing. Second, prioritise protein at every meal: it supports satiety (which Mounjaro is already amplifying), preserves lean mass, and costs your body more energy to digest than fat or carbohydrate. Third, resistance exercise, even light bodyweight training twice a week, helps protect muscle during caloric restriction and keeps metabolism ticking. Some people also ask whether combining treatments could help at this stage, and if that question has crossed your mind, our page on stacking tirzepatide with retatrutide sets out what the current evidence and clinical thinking looks like. The full treatment information for Mounjaro outlines how lifestyle changes sit alongside the medicine.

It is also worth checking in with how you feel, not just what the scales say. Measurements, how clothes fit, and energy levels sometimes tell a more complete story than weight alone, particularly during a phase of body recomposition where fat is being replaced by muscle.

If you have been managing your Mounjaro treatment elsewhere and feel your progress has stalled, our clinical team is available seven days a week. You can start a free consultation at any point; a GPhC-registered prescriber, not an automated system, will review your situation the same day you submit your details. The NHS tirzepatide patient information is a sound reference for what the medicine does and does not do. Our clinical team is happy to answer questions you can't find there.